FDA Inspection 1057467 — South Texas Blood & Tissue Center

South Texas Blood & Tissue Center — FEI 1676815

The FDA completed an inspection of South Texas Blood & Tissue Center on Jun 19, 2018 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 19, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
San Antonio, TX (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.